US Stock MarketDetailed Quotes

PRQR ProQR Therapeutics

Watchlist

1.8300
-0.0200-1.08%

Close Sep 16 16:00 ET

1.8200
-0.0100-0.55%

Post 16:53 ET

149.47MMarket Cap-6120P/E (TTM)

ProQR Therapeutics News

News

Announcement

Ratings

All

Earnings

Transactions

Shareholding

Events

Other

ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
May 23 04:22
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
May 8 20:13
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 23 19:09
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 19 19:08
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 13 19:13
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 15 20:52
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 19 13:00
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 5 13:00
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 8, 2023 20:37
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Sep 27, 2023 19:06
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aug 1, 2023 19:15
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
May 18, 2023 04:05
ProQR Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 18, 2023 20:05
ProQR Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers
Mar 30, 2023 04:53
ProQR Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 29, 2023 20:07
ProQR Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 11, 2023 05:10
ProQR Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Sep 22, 2022 04:16
ProQR Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Aug 11, 2022 19:33
ProQR Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jul 1, 2022 04:32
ProQR Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jun 1, 2022 19:05

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data